{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:09:49Z","timestamp":1789646989274,"version":"4.0.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiologic Clinics of North America"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rcl.2025.03.017","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T15:53:25Z","timestamp":1746201205000},"page":"849-859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Guidelines and Controversies of Computed Tomography and Magnetic Resonance Imaging Contrast Media"],"prefix":"10.1016","volume":"63","author":[{"given":"Madeleine","family":"Sertic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"Glazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rcl.2025.03.017_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.mric.2017.06.002","article-title":"Historical perspective of imaging contrast agents","volume":"25","author":"Zamora","year":"2017","journal-title":"Magn Reson Imag Clin N Am"},{"key":"10.1016\/j.rcl.2025.03.017_bib2","unstructured":"American College of Radiology, Committee on Drugs and Contrast Media ACR manual on contrast media. 2024. Available at: https:\/\/www.acr.org\/Clinical-Resources\/Clinical-Tools-and-Reference\/Contrast-Manual (Accessed 19 March 2025)."},{"issue":"6","key":"10.1016\/j.rcl.2025.03.017_bib3","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1148\/rg.2015150033","article-title":"Safe use of contrast media: what the radiologist needs to know","volume":"35","author":"Beckett","year":"2015","journal-title":"Radiographics"},{"key":"10.1016\/j.rcl.2025.03.017_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/08465371241311253","article-title":"CAR\/CSACI practice guidance for contrast media hypersensitivity","author":"Byrne","year":"2025","journal-title":"Can Assoc Radiol J"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/08465371221083970","article-title":"Canadian association of radiologists guidance on contrast associated acute kidney injury","volume":"73","author":"Macdonald","year":"2022","journal-title":"Can Assoc Radiol J"},{"issue":"15","key":"10.1016\/j.rcl.2025.03.017_bib8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury","volume":"51","author":"McCullough","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.rcl.2025.03.017_bib9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","article-title":"Hospital-acquired renal insufficiency","volume":"39","author":"Nash","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.rcl.2025.03.017_bib10","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.30037","article-title":"Risk of acute kidney injury following IV iodinated contrast media exposure: 2023 update, from the AJR special series on contrast media","volume":"223","author":"McDonald","year":"2024","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib11","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.07.3280","article-title":"Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity","volume":"191","author":"Newhouse","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2214\/AJR.08.1310","article-title":"Contrast-induced nephropathy: contrast material not required?","volume":"191","author":"Baumgarten","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1148\/radiol.2019192094","article-title":"Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of radiology and the national kidney foundation","volume":"294","author":"Davenport","year":"2020","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1148\/radiol.13122276","article-title":"Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate","volume":"268","author":"Davenport","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.rcl.2025.03.017_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1148\/radiol.12121394","article-title":"Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material","volume":"267","author":"Davenport","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.rcl.2025.03.017_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.13130775","article-title":"Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate","volume":"271","author":"McDonald","year":"2014","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1148\/radiol.14132418","article-title":"Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality","volume":"273","author":"McDonald","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.rcl.2025.03.017_bib18","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.29139","article-title":"Development and validation of a risk model for predicting contrast-associated acute kidney injury in patients with cancer: evaluation in over 46,000 CT scans","author":"Gupta","year":"2023","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.rcl.2025.03.017_bib19","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222321","article-title":"Contrast-enhanced CT and acute kidney injury: risk stratification by diabetic status and kidney function","volume":"307","author":"Lee","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.rcl.2025.03.017_bib20","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.22.27494","article-title":"Utility of patient-reported risk factors for identifying advanced chronic kidney disease prior to outpatient CT: comparison with recent ACR\/NKF consensus criteria","author":"Abbasi","year":"2022","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.rcl.2025.03.017_bib21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ejrad.2015.04.001","article-title":"Screening for impaired renal function in outpatients before iodinated contrast injection: comparing the Choyke questionnaire with a rapid point-of-care-test","volume":"84","author":"Too","year":"2015","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.rcl.2025.03.017_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10140-012-1081-9","article-title":"Allergic reactions to iodinated contrast media: premedication considerations for patients at risk","volume":"20","author":"Schopp","year":"2013","journal-title":"Emerg Radiol"},{"issue":"6","key":"10.1016\/j.rcl.2025.03.017_bib23","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2214\/ajr.176.6.1761385","article-title":"Trends in adverse events after IV administration of contrast media","volume":"176","author":"Cochran","year":"2001","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.rcl.2025.03.017_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2214\/ajr.184.1.01840031","article-title":"Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital","volume":"184","author":"Mortel\u00e9","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1148\/radiology.175.3.2343107","article-title":"Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media","volume":"175","author":"Katayama","year":"1990","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1148\/radiology.203.3.9169676","article-title":"Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration","volume":"203","author":"Lasser","year":"1997","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.rcl.2025.03.017_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2214\/ajr.156.4.1825900","article-title":"The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis","volume":"156","author":"Caro","year":"1991","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.rcl.2025.03.017_bib28","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.rcl.2024.02.014","article-title":"Iodine and gadolinium contrast reactions: what is the risk and role of premedication, abbreviated protocols, prior history of reactions, and cross-reactivity?","volume":"62","author":"Mervak","year":"2024","journal-title":"Radiol Clin North Am"},{"issue":"1","key":"10.1016\/j.rcl.2025.03.017_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2214\/AJR.14.13810","article-title":"Rates of breakthrough reactions in inpatients at high risk receiving premedication before contrast-enhanced CT","volume":"205","author":"Mervak","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib30","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1148\/radiol.2532090465","article-title":"Repeat contrast medium reactions in premedicated patients: frequency and severity","volume":"253","author":"Davenport","year":"2009","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.rcl.2025.03.017_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1148\/radiol.2021210490","article-title":"Prevention of allergic-like reactions at repeat CT: steroid pretreatment versus contrast material substitution","volume":"301","author":"McDonald","year":"2021","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib32","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1148\/radiol.2015151143","article-title":"Indirect cost and harm attributable to oral 13-hour inpatient corticosteroid prophylaxis before contrast-enhanced CT","volume":"279","author":"Davenport","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.rcl.2025.03.017_bib33","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220370","article-title":"Iodinated contrast media substitution to prevent recurrent hypersensitivity reactions: a systematic review and meta-analysis","author":"Umakoshi","year":"2022","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.rcl.2025.03.017_bib34","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s00261-024-04409-2","article-title":"Use of oral contrast in 2024: primer for radiologists","volume":"49","author":"Patel","year":"2024","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"10.1016\/j.rcl.2025.03.017_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2214\/AJR.19.21989","article-title":"Positive oral contrast material for abdominal CT: current clinical indications and areas of controversy","volume":"215","author":"Pickhardt","year":"2020","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib36","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s00261-020-02722-0","article-title":"Emergency department length of stay following discontinuation of routine oral contrast material","volume":"46","author":"Kim","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"12","key":"10.1016\/j.rcl.2025.03.017_bib37","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jacr.2017.06.036","article-title":"Patient-centered assessment of the value of oral contrast material","volume":"14","author":"Woolen","year":"2017","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.rcl.2025.03.017_bib38","article-title":"Contrast media in pregnant and lactating patients, from the AJR special series on contrast media","author":"Bookwalter","year":"2024","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib39","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1148\/radiol.10100163","article-title":"Neonatal thyroid function: effect of a single exposure to iodinated contrast medium in utero","volume":"256","author":"Bourjeily","year":"2010","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/RCT.0b013e31824cc048","article-title":"Effect of in utero exposure of iodinated intravenous contrast on neonatal thyroid function","volume":"36","author":"Kochi","year":"2012","journal-title":"J Comput Assist Tomogr"},{"issue":"9234","key":"10.1016\/j.rcl.2025.03.017_bib41","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxoedema-like cutaneous diseases in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib42","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2214\/AJR.07.3115","article-title":"Nephrogenic systemic fibrosis: a report of 29 cases","volume":"190","author":"Shabana","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.rcl.2025.03.017_bib43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1148\/radiol.2451070353","article-title":"Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort","volume":"245","author":"Collidge","year":"2007","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.rcl.2025.03.017_bib44","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2214\/AJR.06.1616","article-title":"ACR guidance document for safe MR practices: 2007","volume":"188","author":"Kanal","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1148\/radiol.2019182916","article-title":"A systematic review of 639 patients with biopsy-confirmed nephrogenic systemic fibrosis","volume":"292","author":"Attari","year":"2019","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.rcl.2025.03.017_bib46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1148\/radiol.2020202903","article-title":"Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of radiology and the national kidney foundation","volume":"298","author":"Weinreb","year":"2021","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib47","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1148\/radiol.2483071863","article-title":"Incidence of nephrogenic systemic fibrosis at two large medical centers","volume":"248","author":"Prince","year":"2008","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2019.5284","article-title":"Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis","volume":"180","author":"Woolen","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1148\/radiol.2020201492","article-title":"Risk of nephrogenic systemic fibrosis in stage 4 and 5 chronic kidney disease following group II gadolinium-based contrast agent administration: subanalysis by chronic kidney disease stage","volume":"297","author":"Shankar","year":"2020","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ackd.2017.03.007","article-title":"Prophylactic hemodialysis for protection against gadolinium-induced nephrogenic systemic fibrosis: a doll\u2019s house","volume":"24","author":"Yee","year":"2017","journal-title":"Adv Chron Kidney Dis"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib51","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2019190104","article-title":"Gadolinium deposition and retention in the brain: should we Be concerned?","volume":"1","author":"Lenkinski","year":"2019","journal-title":"Radiol Cardiothorac Imaging"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib52","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","author":"Kanda","year":"2014","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib53","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.30036","article-title":"Update on gadolinium-based contrast agent safety, from the AJR special series on contrast media","volume":"223","author":"Starekova","year":"2024","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib54","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1148\/radiol.2021211349","article-title":"Symptoms associated with gadolinium exposure (SAGE): a suggested term","volume":"302","author":"McDonald","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.rcl.2025.03.017_bib55","unstructured":"Research C for DE and. FDA Drug Safety Communication, FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings, 2023, FDA. Available at: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-gadolinium-based-contrast-agents-gbcas-are-retained-body."},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2214\/AJR.15.15842","article-title":"Gadolinium in humans: a family of disorders","volume":"207","author":"Semelka","year":"2016","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib57","doi-asserted-by":"crossref","first-page":"W138","DOI":"10.2214\/AJR.10.4885","article-title":"Incidence of immediate gadolinium contrast media reactions","volume":"196","author":"Prince","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.rcl.2025.03.017_bib58","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/RLI.0000000000000573","article-title":"Preventive effect of changing contrast media in patients with A prior mild immediate hypersensitivity reaction to gadolinium-based contrast agent","volume":"54","author":"Ryoo","year":"2019","journal-title":"Investig Radiol"},{"issue":"9","key":"10.1016\/j.rcl.2025.03.017_bib59","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3348\/kjr.2024.0248","article-title":"Changing gadolinium-based contrast agents to prevent recurrent acute adverse drug reactions: 6-year cohort study using propensity score matching","volume":"25","author":"Han","year":"2024","journal-title":"Korean J Radiol"},{"issue":"9","key":"10.1016\/j.rcl.2025.03.017_bib60","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.2016.12126","article-title":"Association between MRI exposure during pregnancy and fetal and childhood outcomes","volume":"316","author":"Ray","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.rcl.2025.03.017_bib61","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1097\/AOG.0000000000002355","article-title":"Committee opinion No. 723: guidelines for diagnostic imaging during pregnancy and lactation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.rcl.2025.03.017_bib62","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1148\/radiol.2431060554","article-title":"Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69,657 intravenous injections","volume":"243","author":"Wang","year":"2007","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.rcl.2025.03.017_bib63","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.acra.2023.09.027","article-title":"Risk factors for contrast media extravasation in intravenous contrast-enhanced computed tomography: an observational cohort study","volume":"31","author":"Liu","year":"2024","journal-title":"Acad Radiol"},{"issue":"2","key":"10.1016\/j.rcl.2025.03.017_bib64","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1148\/radiol.12111605","article-title":"Preparative fasting for contrast-enhanced CT: reconsideration","volume":"263","author":"Lee","year":"2012","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.rcl.2025.03.017_bib65","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2214\/ajr.157.6.1950858","article-title":"Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment","volume":"157","author":"Bush","year":"1991","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.rcl.2025.03.017_bib66","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00330-020-07255-0","article-title":"Is fasting still necessary prior to contrast-enhanced computed tomography? A randomized clinical study","volume":"31","author":"Neeman","year":"2021","journal-title":"Eur Radiol"},{"issue":"1090","key":"10.1016\/j.rcl.2025.03.017_bib67","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180198","article-title":"The effect of preparative solid food status on the occurrence of nausea, vomiting and aspiration symptoms in enhanced CT examination: prospective observational study","volume":"91","author":"Li","year":"2018","journal-title":"Br J Radiol"}],"container-title":["Radiologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033838925000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033838925000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:06:30Z","timestamp":1761181590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033838925000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0033838925000302"],"URL":"https:\/\/doi.org\/10.1016\/j.rcl.2025.03.017","relation":{},"ISSN":["0033-8389"],"issn-type":[{"value":"0033-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines and Controversies of Computed Tomography and Magnetic Resonance Imaging Contrast Media","name":"articletitle","label":"Article Title"},{"value":"Radiologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcl.2025.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}